Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Jiajian Guishen Optimized Formula on Premature Ovarian Insufficiency
NCT07843030Phase 1Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in premature ovarian insufficiency (POI) (2 arms). Primary endpoint: Serum Follicle-Stimulating Hormone at 3 months. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT07843030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07843030.